Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Germ Cell and Embryonal × Gefitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 120 Lung Neoplasms 42 Breast Neoplasms 23 Head and Neck Neoplasms 20 Adenocarcinoma of Lung 17 Brain Neoplasms 14 Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 10 Adenocarcinoma, Bronchiolo-Alveolar 10 Glioblastoma 9 Prostatic Neoplasms 8 NSCLC 8 Esophageal Neoplasms 8 Colorectal Neoplasms 8 Rectal Neoplasms 7 Neoplasm Metastasis 7 Gliosarcoma 7 Colonic Neoplasms 7 Ovarian Neoplasms 6 Adenocarcinoma Of Esophagus 6 Adenocarcinoma 5 Urinary Bladder Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Central Nervous System Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Skin Neoplasms 3 Pancreatic Neoplasms 3 Kidney Neoplasms 3

Interventions

Cisplatin 13 Etoposide 11 Paclitaxel 8 Cyclophosphamide 7 Carboplatin 7 Ifosfamide 6 etoposide phosphate 5 Granulocyte Colony-Stimulating Factor 5 Gemcitabine 5 pembrolizumab 4 fludarabine 4 Sirolimus 4 Bleomycin 4 fludarabine phosphate 3 Sunitinib 3 Oxaliplatin 3 Mesna 3 Melphalan 3 Filgrastim 3 Drug Therapy 3 Brentuximab Vedotin 3 Bevacizumab 3 Automobiles 3 130-nm albumin-bound paclitaxel 3 tremelimumab 2 sodium thiosulfate 2 ribociclib 2 pralsetinib 2 pegfilgrastim 2 lutetium Lu 177 dotatate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00198159 2014-09-19

IUCRO-0021

Indiana University

Phase 2 Terminated

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡